Experimental Type of group

3 trials

Sponsors

UNIVERSIDAD PERUANA CAYETANO HEREDIA,, Marina de Guerra del Peru,, F. HOFFMANN-LA ROCHE LTD.,

Unknown Phase

Active, not recruitingPER-012-99

UNIVERSIDAD PERUANA CAYETANO HEREDIA,

Target: 34Updated: 2023-09-04

RANDOMIZED PHASE 2 CLINICAL TRIAL TO EVALUATE SAFETY AND EFFICACY OF THE USE OF PLASMA FROM CONVALESCENT PATIENTS WITH THE NEW CORONAVIRUS DISEASE (COVID-19) FOR THE EXPERIMENTAL TREATMENT OF PATIENTS HOSPITALIZED IN THE CENTRO MEDICO NAVAL "CIRUJANO MAYOR SANTIAGO TAVARA" "

RecruitingPER-060-20

Marina de Guerra del Peru,

Start: 2020-09-07Target: 100Updated: 2025-05-26

A MULTICENTER, OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY AND TOLERABILITY OF FARICIMAB IN PATIENTS WITH DIABETIC MACULAR EDEMA

RecruitingPER-080-20

F. HOFFMANN-LA ROCHE LTD.,

Start: 2021-01-01Target: 15Updated: 2024-08-20